Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Clinical trial NCT00288600 · COMPLETED

Trial details

NCT number: NCT00288600
Sponsor: Oswaldo Cruz Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperbilirubinemia Erythroblastosis, Fetal

Start date: 2006-10-01
Primary completion: 2010-06-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.